George W. Sledge Jr., MD, Stanford Cancer Center
Advertisement
Articles by George W. Sledge Jr., MD, Stanford Cancer Center
Advertisement
Latest Updated Articles
Metastatic Breast Cancer: Chemotherapy SelectionPublished: January 26th 2021 | Updated:
Assessing Response to Chemotherapy in Metastatic Breast CancerPublished: January 19th 2021 | Updated:
MBC Therapy: Tesetaxel/CapecitabinePublished: February 16th 2021 | Updated:
Treatment Advances in Metastatic Breast CancerPublished: January 19th 2021 | Updated:
Using Oral Therapies to Advance Care in MBCPublished: February 16th 2021 | Updated:
At-Home Administration of Therapies to Treat MBCPublished: February 9th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5